Literature DB >> 24026637

Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro.

Nady Braidy1, Wei-Ping Gai, Ying Hua Xu, Perminder Sachdev, Gilles J Guillemin, Xing-Mai Jiang, J William O Ballard, Martin P Horan, Zhi Ming Fang, Beng H Chong, Daniel Kam Yin Chan.   

Abstract

Parkinson's disease (PD) is a multicentred neurodegenerative disorder characterised by the accumulation and aggregation of alpha-synuclein (α-syn) in several parts of the central nervous system. However, it is well established that PD can generate symptoms of constipation and other gastrointestinal problems and α-syn containing lesions have been identified in intestinal nerve cells. In this study, we show that α-syn can be taken up and accumulate in primary human foetal enteric neurons from the gastrointestinal tract and can be transferred between foetal enteric neurons. Impaired proteosomal/lysosomal degradation can promote the uptake and accumulation of α-syn in enteric neurons. Enteric neurons exposed to α-syn can also lead to impaired mitochondrial complex I activity, reduced mitochondrial function, and NAD(+) depletion culminating in cell death via energy restriction. These findings demonstrate neuron-to-neuron transmission of α-syn in enteric neurons, providing renewed evidence for Braak's hypothesis and the aetiology of PD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24026637     DOI: 10.1007/s12640-013-9420-5

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  65 in total

Review 1.  Parallel manifestations of neuropathologies in the enteric and central nervous systems.

Authors:  G Natale; L Pasquali; A Paparelli; F Fornai
Journal:  Neurogastroenterol Motil       Date:  2011-09-26       Impact factor: 3.598

2.  Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells.

Authors:  S L Budd; D G Nicholls
Journal:  J Neurochem       Date:  1996-12       Impact factor: 5.372

Review 3.  The role of MPTP in Parkinson's disease: connecting brain and gut?

Authors:  O Goetze; D Woitalla
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

4.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

5.  An improved cycling assay for nicotinamide adenine dinucleotide.

Authors:  C Bernofsky; M Swan
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

6.  In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

Authors:  Michelle T Fodero-Tavoletti; David P Smith; Catriona A McLean; Paul A Adlard; Kevin J Barnham; Lisa E Foster; Laura Leone; Keyla Perez; Mikhalina Cortés; Janetta G Culvenor; Qiao-Xin Li; Katrina M Laughton; Christopher C Rowe; Colin L Masters; Roberto Cappai; Victor L Villemagne
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

Review 7.  Common inflammatory mechanisms in Lewy body disease and Alzheimer disease.

Authors:  Robert E Mrak; W Sue T Griffin
Journal:  J Neuropathol Exp Neurol       Date:  2007-08       Impact factor: 3.685

8.  Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease.

Authors:  Andrea Gold; Zorbey T Turkalp; David G Munoz
Journal:  Mov Disord       Date:  2013-01-29       Impact factor: 10.338

9.  Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition.

Authors:  Francesco Fornai; Paola Lenzi; Marco Gesi; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Riccardo Ruffoli; Paola Soldani; Stefano Ruggieri; Maria G Alessandri; Antonio Paparelli
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

10.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

View more
  11 in total

Review 1.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

Review 2.  The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

Authors:  J Schapansky; J D Nardozzi; M J LaVoie
Journal:  Neuroscience       Date:  2014-10-02       Impact factor: 3.590

Review 3.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

4.  Neuroprotective effects of rosmarinic acid on ciguatoxin in primary human neurons.

Authors:  N Braidy; A Matin; F Rossi; M Chinain; D Laurent; G J Guillemin
Journal:  Neurotox Res       Date:  2013-10-05       Impact factor: 3.911

5.  Interference of α-Synuclein Uptake by Monomeric β-Amyloid1-40 and Potential Core Acting Site of the Interference.

Authors:  Daniel K Y Chan; Nady Braidy; Ying Hua Xu; Tim Chataway; Feng Guo; Gilles J Guillemin; Charlie Teo; Wei Ping Gai
Journal:  Neurotox Res       Date:  2016-06-30       Impact factor: 3.911

Review 6.  Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.

Authors:  Lisa Klingelhoefer; Heinz Reichmann
Journal:  Nat Rev Neurol       Date:  2015-10-27       Impact factor: 42.937

7.  Products of the Parkinson's disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival.

Authors:  Yusuke Toyoda; Cihan Erkut; Francisco Pan-Montojo; Sebastian Boland; Martin P Stewart; Daniel J Müller; Wolfgang Wurst; Anthony A Hyman; Teymuras V Kurzchalia
Journal:  Biol Open       Date:  2014-07-25       Impact factor: 2.422

8.  Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.

Authors:  Tharusha Jayasena; Anne Poljak; Nady Braidy; George Smythe; Mark Raftery; Mark Hill; Henry Brodaty; Julian Trollor; Nicole Kochan; Perminder Sachdev
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 9.  Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.

Authors:  Martin P Helley; Jennifer Pinnell; Carolina Sportelli; Kim Tieu
Journal:  Front Genet       Date:  2017-11-17       Impact factor: 4.599

Review 10.  Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology.

Authors:  Francisco Pan-Montojo; Heinz Reichmann
Journal:  Transl Neurodegener       Date:  2014-05-09       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.